BIOMAT Database Logo BIOMAT Database Logo

[Pharmacokinetics of antibiotics in bronchial secretions. 250 cases]. 1977

E Bergogne-Berezin, and N Lambert-Zechovsky, and C Morel

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

E Bergogne-Berezin, and N Lambert-Zechovsky, and C Morel
Pharmacokinetics of azlocillin in bronchial secretions.
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
E Bergogne-Berezin, and N Lambert-Zechovsky, and C Morel
[Pharmacokinetics of amikacin in bronchial secretions].
October 1979, La Nouvelle presse medicale,
E Bergogne-Berezin, and N Lambert-Zechovsky, and C Morel
Pharmacokinetics of gentamicin sulfate in bronchial secretions.
February 1975, The Journal of infectious diseases,
E Bergogne-Berezin, and N Lambert-Zechovsky, and C Morel
[Pharmacokinetics of mezlocillin in bronchial secretions (author's transl)].
February 1982, La Nouvelle presse medicale,
E Bergogne-Berezin, and N Lambert-Zechovsky, and C Morel
RV11 (propionyl erythromycin mercaptosuccinate) pharmacokinetics in bronchial secretions.
January 1986, The Journal of international medical research,
E Bergogne-Berezin, and N Lambert-Zechovsky, and C Morel
Pharmacokinetic study of beta-lactam antibiotics in bronchial secretions.
January 1978, Scandinavian journal of infectious diseases. Supplementum,
E Bergogne-Berezin, and N Lambert-Zechovsky, and C Morel
Bronchial carcinoma. Lobar distribution of lesions in 250 cases.
January 1961, California medicine,
E Bergogne-Berezin, and N Lambert-Zechovsky, and C Morel
[Pharmacokinetics of apalcillin (PC 904). Study of penetration into bronchial secretions].
May 1983, Pathologie-biologie,
E Bergogne-Berezin, and N Lambert-Zechovsky, and C Morel
Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.
February 1988, The Journal of antimicrobial chemotherapy,
E Bergogne-Berezin, and N Lambert-Zechovsky, and C Morel
Unidentified bronchial objects in bronchial secretions.
January 1986, Acta cytologica,
Copied contents to your clipboard!